» Articles » PMID: 22224700

Omission of in Vivo T-cell Depletion Promotes Rapid Expansion of Naïve CD4+ Cord Blood Lymphocytes and Restores Adaptive Immunity Within 2 Months After Unrelated Cord Blood Transplant

Abstract

Umbilical cord blood transplant (UCBT) is associated with impaired early immune reconstitution. This might be explained by a lower T-cell dose infused, the naivety of cord blood T-cells and the use of in vivo T-cell depletion. We studied the pattern of early immune reconstitution and the clinical outcome of children undergoing unrelated UCBT when in vivo T-cell depletion was omitted. Thirty children affected by malignancies (46%) or immunodeficiencies (54%) underwent an unrelated UCBT. Prospective assessment of immune reconstitution and clinical outcome was performed. We observed an unprecedented CD4(+) T-cell reconstitution, with a median cell count at 30 and 60 d post UCBT of 0.3 × 10(9) /l and 0.56 × 10(9) /l, respectively. Early T-cell expansion was thymic-independent, with a rapid shift from naïve to central memory phenotype and early regulatory T-cell recovery. Viral infections were frequent (63%) but resolved rapidly in most cases and virus-specific T-lymphocytes were detected within 2 months post-UCBT. Acute graft-versus-host disease (GvHD) was frequent (grade II = 34%, grade III-IV = 16%) but steroid responsive, and the incidence of chronic GvHD was low (14%). The omission of in vivo T-cell depletion promotes a unique thymic-independent CD4(+) T-cell reconstitution after unrelated UCBT in children. We postulate that this relates to the specific immunological and ontological qualities of fetal-derived lymphocytes.

Citing Articles

Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant options.

Georgiadis C, Nickolay L, Syed F, Zhan H, Gkazi S, Etuk A Haematologica. 2024; 109(12):3941-3951.

PMID: 38988258 PMC: 11609806. DOI: 10.3324/haematol.2024.285101.


Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.

Cordon L, Chorao P, Martin-Herreros B, Montoro J, Balaguer A, Guerreiro M Ann Hematol. 2024; 103(7):2475-2484.

PMID: 38634914 DOI: 10.1007/s00277-024-05758-0.


Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia.

Borrill R, Poulton K, Wynn R Front Pediatr. 2023; 11:1232281.

PMID: 37780051 PMC: 10534014. DOI: 10.3389/fped.2023.1232281.


T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

Horgan C, Mullanfiroze K, Rauthan A, Patrick K, Butt N, Mirci-Danicar O Blood Adv. 2023; 7(10):2155-2165.

PMID: 36649566 PMC: 10206437. DOI: 10.1182/bloodadvances.2022009253.


Are homeostatic mechanisms aiding the reconstitution of the T-cell pool during lymphopenia in humans?.

Baliu-Pique M, Tesselaar K, Borghans J Front Immunol. 2022; 13:1059481.

PMID: 36483556 PMC: 9723355. DOI: 10.3389/fimmu.2022.1059481.